Scott Oakes appointed associate dean for clinical science research

Scott Oakes, MD, has been named associate dean for the Department of Biological Sciences and Clinical Scientific Research at the Pritzker School of Medicine.

The Associate Dean for Clinical Science Research is a new leadership role responsible for the successful implementation of research strategic plans related to clinical science within the overall BSD/PSOM research mission. Oakes will play a central role in developing the department’s research strategic plan, along with Dr. Conrad Gilliam, associate dean for basic science research. He will report to Mark Anderson, MD, PhD, Dean of BSD and PSOM, and Iris Romero, MD, PhD, Associate Dean of BSD, and will serve as a strategic leader for the Dean’s Office and provide leadership to the entire BSD research organization. This will create a synergistic effect. By working closely with the Associate Dean for Clinical Research, clinical research leaders, the Pritzker School of Medicine, and the University of Chicago Medical Center,

Oakes is a professor and vice chair for research and academic affairs in the Department of Pathology. He is also co-leader of the Cancer Molecular Mechanisms Program at the University of Chicago Medicine Comprehensive Cancer Center. His lab focuses on how mammalian cells adapt or self-destruct in response to different forms of damage, and what goes wrong with this process in cancer and other diseases. Masu.

In his role as Associate Chair for Research in the Department of Pathology, he mentors the department’s research faculty, oversees pre- and post-award administrators, and leads the development of new research faculty, including four new BSD track faculty in the past four years. Oversees recruitment research. Year. He also directs the Department of Pathology’s Physician-Scientist Development Program.

Oakes joined the University of Chicago faculty in 2019 after 14 years on the faculty at the University of California, San Francisco. He earned a bachelor’s degree in biochemistry from Elmira College and a medical degree from the University of Connecticut. He completed his residency at Brigham and Women’s Hospital and his postdoctoral fellowship at Dana-Farber Cancer Institute.